Stay updated on AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial
Sign up to get notified when there's something new on the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page.

Latest updates to the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record history shows a new revision entry (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure and an older revision entry (v3.3.2), which are minor metadata updates to the site. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedA new revision entry v3.3.2 has been added to the Study Record Versions, replacing the previous v3.2.0 entry.SummaryDifference0.1%

- Check46 days agoChange DetectedThe banner notice about government funding and operating status was removed from the page.SummaryDifference0.8%

- Check60 days agoChange DetectedThe Record History shows multiple version updates with changes to Recruitment Status and Study Status (e.g., 2021-02-01, 2021-05-27, 2021-06-17, 2023-10-26), reflecting the evolving status of the trial.SummaryDifference0.1%

- Check89 days agoChange Detected- Added a government funding status notice and operating details for the NIH Clinical Center, plus a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference13%

- Check96 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.3%

Stay in the know with updates to AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page.